Asia Pacific Pharmaceutical: Wholly-owned subsidiary plans to invest 6 million yuan to establish a joint venture company.

Asia-Pacific Pharmaceuticals announced that its wholly-owned subsidiary Yatai Li Zhong signed an "Investment Cooperation Agreement" with Hainan Taizefeng Medical Technology Co., Ltd. to jointly invest in the establishment of Zhejiang Yataixinghao Pharmaceutical Co., Ltd. The joint venture company has a registered capital of 10 million yuan, with Yatai Li Zhong contributing 6 million yuan and holding a 60% stake, while Taizefeng Medical contributes 4 million yuan and holds a 40% stake. This investment does not constitute a related party transaction or a major asset restructuring, and aims to optimize the business structure, expand profit channels, and cultivate new profit growth points.